Enzon Pharmaceuticals buy DomRuinart
Start price
01.12.20
/
50%
€0.12
Target price
01.12.21
€0.000
Performance (%)
49.17%
End price
14.12.20
€0.18
Summary
This prediction ended on 14.12.20 with a price of €0.18. With a performance of 49.17% the BUY prediction by DomRuinart was a big success. DomRuinart has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enzon Pharmaceuticals | 0.000% | 0.000% | -99.383% | -99.734% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% | 45.717% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% | 73.262% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% | 48.769% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% | 55.803% |
According to DomRuinart what are the pros and cons of Enzon Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Enzon Pharmaceuticals diskutieren
Buy mit Kursziel 0,0